bilateral basal ganglia involvement in a patient with griscelli syndrome
TRANSCRIPT
Official Journal of the European Paediatric Neurology Society
Case study
Bilateral basal ganglia involvement in a patient withGriscelli syndrome
Mahmoud Reza Ashrafi�, Meysam Mohseni, Shahrooz Yazdani, Houman Alizadeh,Asghar Ramyar, Asghar Aghamohammadi, Mina Izadyar, Fatemeh Mahjoub,Javad Ahmadian Heris
Children hospital Medical Center, Tehran University of Medical Sciences, Pediatric Neurology, Tehran 1419733151, Iran
a r t i c l e i n f o
Article history:
Received 12 June 2006
Received in revised form
20 July 2006
Accepted 30 July 2006
Keywords:
Griscelli Syndrome
Partial albinism
Neurological involvement
A B S T R A C T
We report a 6-year-old Iranian boy with silvery-gray hair, eyelashes and the eyebrows who
was admitted because of seizures and subsequent stupor. He had previous history of acute
hemiparesis at 1 year of age and hepatitis-like syndrome 3 months ago. Microscopic
examination of the patient’s hair shaft revealed different sized clumps of melanin seen in
the center of the shafts. Bone marrow aspiration revealed erythroid hyperplasia and
erythrophagocytic cells. Bilateral frontal cortical and subcortical high signal lesions, dirty
white matter, high signal areas in the upper pons and in both caudates and lentiform
nuclei in T2 WI were the brain MRI findings of the patient. He died in the accelerated phase
of Griscelli Syndrome (GS) type 2. To our knowledge we report the first case of GS from Iran.
& 2006 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.
1. Introduction
In 1978, Griscelli and colleagues initially described a disorder
resembling the Chediak-Higashi syndrome (CHS) in two
children with partial albinism, frequent infections, acute
episodes of fever, neutropenia and thrombocytopenia1
and since then more than 60 patients with Griscelli Syndrome
(GS) have been reported in the literature. GS is a rare
recessively inherited hypopigmentation disorder that results
in pigmentary dilution of the skin and the hair, the presence
of large clumps of pigment in hair shafts, variable cellular
immune deficiency and occurrence of uncontrolled lympho-
cyte and macrophage activation with consequent neurological
deficits.1,2
Two closely linked genes (RAB27A and MYO5A) on chromo-
some 15q21 region have been found to be responsible for the
GS.3 According to mutation analysis three subtypes have been
described.
GS type 1 (GS1) represents hypomelanosis with a primary
neurologic deficit and without immunologic impairment
which is caused by mutations in the MYO5A gene.3,4 Patients
exhibit severe developmental delay and mental retardation
occurring early in life.
GS type 2 (GS2) is characterized by partial albinism,
immunodeficiency and hemophagocytic syndrome (HS)
which is caused by mutation in RAB27A gene.3,4
HS or accelerated phase is characterized by lymphoid organ
and extranodal infiltration including the brain by polyclonal
activated T cells and macrophages. HS usually results in
death unless the child receives a bone marrow transplant.
GS type 3 (GS3) is characterized by hypomelanosis without
immunologic or neurologic manifestations which is due to
mutation of melanophilin or MYO5A genes.
In the present study we report a 6-year-old Iranian boy with
GS. We describe the clinical and paraclinical manifestations
with emphasis on neurological and neuroimaging findings.
ARTICLE IN PRESS
1090-3798/$ - see front matter & 2006 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.doi:10.1016/j.ejpn.2006.07.005
�Corresponding author. Tel.: +98 2166935848; fax: +98 2166930024.E-mail address: [email protected] (M.R. Ashrafi).
E U R O P E A N J O U R N A L O F PA E D I AT R I C N E U R O L O G Y 1 0 ( 2 0 0 6 ) 2 0 7 – 2 0 9
2. Case presentation
A 6-year-old boy was referred to Children’s Medical Center of
Tehran University of Medical Sciences because of decreased level
of consciousness, seizure disorder and fever.
During the previous 6 weeks, the patient became febrile
with three episodes of tonic-clonic seizures. Depression of
consciousness manifested as the third episode occurred.
He was the third child of consanguineous parents and was
delivered at term during a caesarian section delivery with
unremarkable birth history. The first child who was a girl also
had silvery-grayish hair and was admitted to a local hospital
with the complaint of jaundice at 3 years of age. She died
after 3 days of admission with unknown etiology. The second
child is a 10-year-old healthy boy with dark brown hair.
The third child, the patient, had no problem through the
first year of life with normal development. He walked
independently at 1 year of age. At 13 months of age he was
first admitted due to acute right-sided hemiplegia and several
episodes of fits. Brain Computed Tomography (CT) scan was
in favor of stroke. Since the first admission, he faced some
neurodevelopmental delays. With the help of frequent
occupational and speech therapies he walked at 3.5 years of
age and spoke at 4 years of age. Except frequent upper
respiratory tract infections, he had no problem until 3 months
ago when he was admitted in a local hospital with the
complaint of jaundice. Hepatomegaly, both direct and indirect
hyperbilirubinemia, mild elevation of liver enzymes and no
evidence of viral hepatitis were the prominent physical
examination and laboratory findings. The patient gradually
improved and discharged with no definite diagnosis.
On the last admission he was responsive only to painful
stimuli, had fever and 3 left-sided cervical lymphadenopa-
thies. Bilateral hyperreflexia, babinski and ankle clonus were
seen. The hair, eyelashes and the eyebrows were silvery-gray
but his skin was slightly bronzed.
Hematologic and biochemistric findings included: hemoglo-
bin (Hgb) ¼ 11.9 gr/dl, white blood cell count (WBC) ¼ 3100/ml,
platelet count (PLT) ¼ 60,000/ml, Prothrombin Time (PT) ¼ 15.5 s,
Partial Thromboplastin Time (PTT) ¼ 41 s, Bleeding Time
(BT) ¼ 2 min, triglyceride ¼ 345 mg/dl and peripheral blood
smear showed no giant cytoplasmic granules in the leuko-
cytes. Bone marrow aspiration revealed erythroid hyperplasia
and some erythrophagocytic cells. The cerebrospinal fluid (CSF)
findings were normal. Ultrasound showed mild splenomegaly.
Delayed-type hypersensitivity skin tests for Purified protein
derivative (PPD) and Candida were negative. Immunopheno-
typing revealed low percentages of CD4+ T-cells and high
percentages of CD8+ T-cells. Serum immunoglobulin levels
were within normal limits.
Electroencephalogram (EEG) showed high-voltage slow waves
and spike–wave complexes.
Microscopic examination of the patient’s hair shaft re-
vealed different sized clumps of melanin seen in the center of
the shafts.
T2 WI of the brain MRI reveals frontal cortical and
subcortical ill-defined high signal lesions, dirty white matter
of both centrum semiovale and periventricular areas, high
signal areas in the upper pons, quadrigeminal plate, bilateral
caudates and lentiform nuclei, interhemispheric tract, right
aspect of the splenium of the corpus callosum and subcortical
left parietal region (Figs. 1A, B, and C).
Within 7 days, stupor changed to coma and spleen became
palpable 4 cm below the costal margin. Hemoglobin de-
creased to 8.6 g/dl and platelet count to 6000 /ml within a
week after admission. Bleeding occurred from catheter sites
on the 10th day of admission.
Despite intensive supportive care, the patient’s clinical
condition worsened and 2 days later cardiopulmonary arrest
happened and the patient expired on the 12th day of
admission. His family refused autopsy.
Based on the family history and some physical features
particularly silvery-gray hair and a hepatits-like syndrome,
we suggested the diagnosis of GS and it was confirmed by
light microscopic examination of hair, bone marrow aspira-
tion analysis and some compatible laboratory data.
3. Discussion
We report an Iranian boy with the diagnosis of GS with some
new neuroradiologic findings who is the first reported case of GS
from Iran.
ARTICLE IN PRESS
Fig. 1 – Brain T2 WI frontal cortical and subcortical high signal lesions and dirty white matter (a), bilateral caudate and
lentiform nucleoli high signal areas (b), high signal area in upper pons (c).
E U R O P E A N J O U R N A L O F PA E D I A T R I C N E U R O L O G Y 1 0 ( 2 0 0 6 ) 2 0 7 – 2 0 9208
The single most consistent expression of partial albinism in
GS is silvery-gray hair, eyebrows and eyelashes, diffuse skin
hypopigmentation and in few reported cases hyperpigmenta-
tion in sun-exposed areas of the skin.
In GS hair shafts contain atypical pattern of uneven
accumulation of large pigment granules in contrast to the
homogenous distribution of small pigment granules in
normal hair and regular, small aggregates of melanin in
CHS.1–3 The skin of the present patient was slightly dark and
his dermatologic findings were limited to pigmentary ab-
normalities of the hair, eyelashes and eyebrows. Microscopic
examination of the patient’s hair revealed irregular large
aggregations of melanin pigment.
Giant cytoplasmic granules in leukocytes which are pathog-
nomonic for CHS were not seen.
A diagnosis of GS was made by the silvery-gray hair and the
characteristic microscopic changes of the hair in association
with the clinical and paraclinical features of accelerated
phase including prolonged fever, jaundice, splenomegaly,
lymphadenopathy, pancytopenia, hypertriglyceridemia and
hemophagocytes in the bone marrow.
The spectrum of neurological involvement in GS may range
from an early onset of severe neurological disorder to the
form that accompanies the accelerated phase.
In GS1, severe neurologic symptoms are noticeable at birth
without any sign of an accelerated phase or immunologic
impairment. Neurologic disorders are stable and never
regresses with time and consist of hypotonia, absence of
coordinated voluntary movements, encephalopathy, hemi-
paresis, peripheral facial palsy, spasticity, seizures and
psychomotor retardation. Congenital cerebellar atrophy is
the main neuroimaging finding in GS1.
Patients with GS2 have neurologic problems related to HS
and a lymphohistiocytic infiltration of the CNS. Neurological
manifestations can be the first sign of an accelerated phase.
The symptoms include hyperreflexia, hypertonia, seizures,
increased intracranial pressure, regression of developmental
milestones, nystagmus, ataxia and fatal degeneration. Psy-
chomotor development is normal primarily and then re-
gresses in HS Encephalopathy, long tract involvement and
previous episode of hemiparesis due to ischemic stroke were
the main neurologic findings of the patient. The neurologic
manifestations of the patient were due to HS and compatible
with GS2. Cerebellar hypodense areas, ventricular dilatation,
generalized white matter changes, periventricular and basal
ganglia calcifications and hyperdense areas compatible
with inflammatory changes are the main neuroimaging
findings in GS2.5 As noted above, our patient had a previous
isolated episode of neurologic symptoms in the early child-
hood which we suggest as an early episode of HS. Since we do
not have access to the patient’s early-childhood-medical
documents, it is not apparent to us that this episode was
due to HS or not.
Bilateral basal ganglia involvement and old necrotic area in
brainstem were the special findings in his brain MRI that in
our knowledge are not reported till now.
GS must be considered in a child with any neurologic
disorders associated with partial albinism.
R E F E R E N C E S
1. Griscelli C, Durandy A, Guy-Grand D, et al. A syndromeassociating partial albinism and immunodeficiency. Am J Med1978;65:691–702.
2. Klein C, Philippe N, Le Deist F, et al. Partial albinism withimmunodeficiency (Griscelli syndrome). J Pediatr1994;125:886–95.
3. Menasche G, Fischer A, de Saint Basile G. Griscelli syndrometypes 1 & 2. Am J Hum Genet 2002;71:1237–8.
4. Mancini AJ, Chan LS, Paller AS. Partial albinism with immuno-deficiency: Griscelli syndrome: report of a case and review ofthe literature. J Am Acad Dermatol 1998;38:295–300.
5. Hurvitz H, Gillis R, Klaus S. A kindred with Griscelli disease:spectrum of neurological involvement. Eur J Pediatr 1993;152:4.
ARTICLE IN PRESS
E U RO P E A N J O U R NA L O F PA E D I AT R I C N EU RO L O G Y 10 (2006) 207 – 209 209